Novel inhalable gene therapy trialed for people with cystic fibrosis
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
Armed robbery in Revesby9h
Inhalable Gene Therapy Trialled for Cystic Fibrosis
Researchers at Imperial College London are leading human trials for the innovative treatmentAn inhalable medicine with the potential to improve lung ...
precisionmedicineonline6h
Boehringer Ingelheim Kicks Off Inhaled Cystic Fibrosis Gene Therapy Phase I/II Trial With Partners
Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.
Tech Xplore on MSN12h
Forcing UK creatives to 'opt out' of AI training risks stifling new talent, report suggests
The UK government should resist allowing AI companies to scrape all copyrighted works unless the holder has actively "opted out," as it puts an unfair burden on up-and-coming creative talents who lack ...
Tech Xplore on MSN3h
Giant X-ray facility shows that magnets can reduce flaws in 3D printed components
Safety critical components for aircraft and Formula 1 racing cars could one day be 3D printed via a new technique, developed ...
News Medical8h
The Latest Advances in Cell and Gene Therapy
The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.